Jointly provided by Postgraduate Institute for Medicine and The Society for Immunotherapy of Cancer
Supported by an independent educational grant from AstraZeneca, Bristol-Myers Squibb, Genentech, Lilly, and Merck & Co., Inc
Presented through detailed written case studies, this activity is designed to provide physicians and registered nurses with a more in-depth overview of what they will need to know when considering and utilizing immunotherapy with non-small cell lung cancer (NSCLC) patients in the clinical setting.
Physicians, oncologists, and other clinicians who treat patients with NSCLC
Upon completion of this activity, participants will be able to:
Describe the key mechanisms and terminology of tumor immunology and cancer immunotherapy
Identify the current immunotherapy treatments for non-small cell lung cancer; including their mechanism of action, adverse events, clinical management, and efficacy
Incorporate immunotherapy in treatment regimens
Differentiate the side effects between immunotherapy treatments and traditional treatments for NSCLC in monitoring and educating
Conflicts of Interest Disclosure Policy
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported any financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty section below.
Maura Abbott, PhD, AOCNP, CPNP Assistant Professor of Nursing Oncology Program Director Columbia University Medical Center
Dr. Abbott has no relevant financial relationships to disclose.
Jarushka Naidoo, MD Assistant Professor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dr. Naidoo has no relevant financial relationships to disclose.
The steering committee reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Julie Brahmer, MD, discloses the following: Consulting Fees: Merck; BMS (non-compensated); Eli Lilly; Celgene Contracted Research: BMS; MedImmune/AstraZeneca; Merck
Ann Lau Clark, RN, MSN, CCRP, CCRC Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (ie: Speakers' Bureau): BMS; Merck
Roy Herbst, MD, PhD, discloses the following: Consulting Fees: Biothera; Diatech; Kolltan Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agent (ie: Speakers' Bureau): AstraZeneca; Boehringer Ingelheim; Eli Lilly; Genentech/Roche; Merck; Pfizer Contracted Research: Genentech; Merck
David Spigel, MD, discloses the following: No relevant financial relationships to disclose.
Accredited Provider Disclosure
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Publishing Staff Disclosure
The following SITC planners and managers, Tara Withington, CAE, Mike Scorzo, Ed.D., and Lianne Wiggins hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Society for Immunotherapy of Cancer. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
In order to receive credit, participants must complete the pre-assessment questions, post-test, and program evaluation. Participants must also score at least 75% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For information about the accreditation of this program, please contact Postgraduate Institute for Medicine at firstname.lastname@example.org or (303) 799-1930.